STADA and Alvotech broaden European patients' options by launching Hukyndra® high-concentration, citrate-free adalimumab - Alvotech
Hemofarm - News - STADA Health Report 2023: Mental Health of Europeans Is Improving
Annual Report 2022 | STADA
Persona che tiene il cellulare con il logo della società tedesca Stada Arzneimittel AG sullo schermo di fronte alla pagina web aziendale. Messa a fuoco sul display del telefono Foto stock -
Investor Relations | STADA
STADA's excellent results in H1 2023 | STADA
Investor Relations | STADA
Ad hoc Releases - Stock - Investor Relations | STADA
STADA Arzneimittel AG - Slide-show-presentation-1T | PDF | Generic Drug | Investor
Financial Reports - Investor Relations | STADA
Investor Relations | STADA
IR Contact - Investor Relations | STADA
Press release: STADA ranks among top 10% of pharma firms on sustainability | Presseportal
Investor Relations | STADA
Investor Relations | STADA
Farmaceutica: il Gruppo STADA continua a crescere anche in tempi difficili
Financial Reports - Investor Relations | STADA
News - Investor Relations | STADA
Nidda Healthcare GmbH - Investor Relations
STADA Arzneimittel AG - Slide-show-presentation-1T | PDF | Generic Drug | Stocks
Annual Report 2022 | STADA
IR Contact - Investor Relations | STADA
Corporate Presentation Investor Relations, May 2015
Annual Report 2022 | STADA
STADA_Press Conference_Invitation_2023.pdf | STADA Arzneimittel AG
STADA diventa uno dei principali player del settore farmaceutico